re: #271 freetoken

That report is a bit out of date.

And, 23andMe dropped its price to $99. Then the FDA made them stop reporting health (and I think 23andMe pulled the traits too.)

Now they’re offering a $199 product that even though it tests for the allele they can’t, or won’t, report the cilantro study. FDA has limited them to reporting only monogenic autosomal recessive disorders.

They do full reporting in Canada. I wonder why the FDA is against it. I’d think knowing about Brest cancer genes, etc. would be beneficial.